Corcept Therapeutics Inc (CORT) Directors and Executive Officers

Officers & Directors

1. Joseph K. Belanoff, M.D. - Chief Executive Officer, President, and Director
Dr. Joseph Belanoff is the co-founder of Corcept Therapeutics and has served as the CEO since its inception in 1998. He is also a board-certified psychiatrist and endocrinologist. Dr. Belanoff has published numerous scientific papers and is a recognized expert in the field of stress-related disorders, particularly in the area of cortisol metabolism.

2. Atabak Mokari - Chief Financial Officer

3. Joseph Douglas Lyon - Chief Accounting Officer

4. Gillian Cannon - Director

5. Kimberly Park - Director

6. David L. Mahoney - Director

7. Joshua Murray - Director

8. Daniel N. Swisher, Jr. - Director

9. G. Leonard Baker, Jr. - Director

10. Gregg Alton - Director

11. James N. Wilson - Director and Chairman of the Board of Directors ,

Corcept Therapeutics Inc currently has 730 employees.

News about Corcept Therapeutics Inc Key Personnel

Corcept Therapeutics Appoints Roberto Vieira as President, Oncology amidst Recent Stock Dip

Combining Articles:
Corcept Therapeutics Incorporated, a leading commercial-stage company specializing in the discovery and development of medications to address severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating cortisol hormone effects, has appointed Roberto Vieira as the new President of Oncology. The announcement was made on January 29, 2024, by Joseph K. Belanoff, MD, Corcept s Chief Executive Officer.
Vieira, an experienced professional in the field, will report directly to Dr. Belanoff and join Corcept s Executive Team. This strategic move aims to bolster the company s efforts in the oncology sector. As an emerging area of focus within Corcept s diverse po...